Cargando…

Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study

OBJECTIVES: To prevent pain inhibiting their performance, many athletes ingest over-the-counter (OTC) analgesics before competing. We aimed at defining the use of analgesics and the relation between OTC analgesic use/dose and adverse events (AEs) during and after the race, a relation that has not be...

Descripción completa

Detalles Bibliográficos
Autores principales: Küster, Michael, Renner, Bertold, Oppel, Pascal, Niederweis, Ursula, Brune, Kay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641448/
https://www.ncbi.nlm.nih.gov/pubmed/23604350
http://dx.doi.org/10.1136/bmjopen-2012-002090
_version_ 1782268025170296832
author Küster, Michael
Renner, Bertold
Oppel, Pascal
Niederweis, Ursula
Brune, Kay
author_facet Küster, Michael
Renner, Bertold
Oppel, Pascal
Niederweis, Ursula
Brune, Kay
author_sort Küster, Michael
collection PubMed
description OBJECTIVES: To prevent pain inhibiting their performance, many athletes ingest over-the-counter (OTC) analgesics before competing. We aimed at defining the use of analgesics and the relation between OTC analgesic use/dose and adverse events (AEs) during and after the race, a relation that has not been investigated to date. DESIGN: Prospective (non-interventional) cohort study, using an online questionnaire. SETTING: The Bonn marathon 2010. PARTICIPANTS: 3913 of 7048 participants in the Bonn marathon 2010 returned their questionnaires. PRIMARY AND SECONDARY OUTCOMES: Intensity of analgesic consumption before sports; incidence of AEs in the cohort of analgesic users as compared to non-users. RESULTS: There was no significant difference between the premature race withdrawal rate in the analgesics cohort and the cohort who did not take analgesics (‘controls’). However, race withdrawal because of gastrointestinal AEs was significantly more frequent in the analgesics cohort than in the control. Conversely, withdrawal because of muscle cramps was rare, but it was significantly more frequent in controls. The analgesics cohort had an almost 5 times higher incidence of AEs (overall risk difference of 13%). This incidence increased significantly with increasing analgesic dose. Nine respondents reported temporary hospital admittance: three for temporary kidney failure (post-ibuprofen ingestion), four with bleeds (post-aspirin ingestion) and two cardiac infarctions (post-aspirin ingestion). None of the control reported hospital admittance. CONCLUSIONS: The use of analgesics before participating in endurance sports may cause many potentially serious, unwanted AEs that increase with increasing analgesic dose. Analgesic use before endurance sports appears to pose an unrecognised medical problem as yet. If verifiable in other endurance sports, it requires the attention of physicians and regulatory authorities.
format Online
Article
Text
id pubmed-3641448
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-36414482013-05-07 Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study Küster, Michael Renner, Bertold Oppel, Pascal Niederweis, Ursula Brune, Kay BMJ Open Sports and Exercise Medicine OBJECTIVES: To prevent pain inhibiting their performance, many athletes ingest over-the-counter (OTC) analgesics before competing. We aimed at defining the use of analgesics and the relation between OTC analgesic use/dose and adverse events (AEs) during and after the race, a relation that has not been investigated to date. DESIGN: Prospective (non-interventional) cohort study, using an online questionnaire. SETTING: The Bonn marathon 2010. PARTICIPANTS: 3913 of 7048 participants in the Bonn marathon 2010 returned their questionnaires. PRIMARY AND SECONDARY OUTCOMES: Intensity of analgesic consumption before sports; incidence of AEs in the cohort of analgesic users as compared to non-users. RESULTS: There was no significant difference between the premature race withdrawal rate in the analgesics cohort and the cohort who did not take analgesics (‘controls’). However, race withdrawal because of gastrointestinal AEs was significantly more frequent in the analgesics cohort than in the control. Conversely, withdrawal because of muscle cramps was rare, but it was significantly more frequent in controls. The analgesics cohort had an almost 5 times higher incidence of AEs (overall risk difference of 13%). This incidence increased significantly with increasing analgesic dose. Nine respondents reported temporary hospital admittance: three for temporary kidney failure (post-ibuprofen ingestion), four with bleeds (post-aspirin ingestion) and two cardiac infarctions (post-aspirin ingestion). None of the control reported hospital admittance. CONCLUSIONS: The use of analgesics before participating in endurance sports may cause many potentially serious, unwanted AEs that increase with increasing analgesic dose. Analgesic use before endurance sports appears to pose an unrecognised medical problem as yet. If verifiable in other endurance sports, it requires the attention of physicians and regulatory authorities. BMJ Publishing Group 2013-04-19 /pmc/articles/PMC3641448/ /pubmed/23604350 http://dx.doi.org/10.1136/bmjopen-2012-002090 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Sports and Exercise Medicine
Küster, Michael
Renner, Bertold
Oppel, Pascal
Niederweis, Ursula
Brune, Kay
Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study
title Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study
title_full Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study
title_fullStr Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study
title_full_unstemmed Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study
title_short Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study
title_sort consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study
topic Sports and Exercise Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641448/
https://www.ncbi.nlm.nih.gov/pubmed/23604350
http://dx.doi.org/10.1136/bmjopen-2012-002090
work_keys_str_mv AT kustermichael consumptionofanalgesicsbeforeamarathonandtheincidenceofcardiovasculargastrointestinalandrenalproblemsacohortstudy
AT rennerbertold consumptionofanalgesicsbeforeamarathonandtheincidenceofcardiovasculargastrointestinalandrenalproblemsacohortstudy
AT oppelpascal consumptionofanalgesicsbeforeamarathonandtheincidenceofcardiovasculargastrointestinalandrenalproblemsacohortstudy
AT niederweisursula consumptionofanalgesicsbeforeamarathonandtheincidenceofcardiovasculargastrointestinalandrenalproblemsacohortstudy
AT brunekay consumptionofanalgesicsbeforeamarathonandtheincidenceofcardiovasculargastrointestinalandrenalproblemsacohortstudy